[1,2,4]triazolo[4,3-
A375 melanoma cell line
EAPB02303
Imiqualines
[1,2,4]triazolo[4,3-a]quinoxaline
anticancer agents
cytotoxic activities
pharmacophore
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
18 Jul 2023
18 Jul 2023
Historique:
received:
27
06
2023
revised:
13
07
2023
accepted:
16
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Cutaneous melanoma is one of the most aggressive human cancers and is the deadliest form of skin cancer, essentially due to metastases. Novel therapies are always required, since cutaneous melanoma develop resistance to oncogenic pathway inhibition treatment. The Imiqualine family is composed of heterocycles diversely substituted around imidazo[1,2-
Identifiants
pubmed: 37513350
pii: molecules28145478
doi: 10.3390/molecules28145478
pmc: PMC10384284
pii:
doi:
Substances chimiques
Quinoxalines
0
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ligue Nationale Contre le Cancer
ID : 6FI15159WJVJ
Références
Blood. 2008 Apr 1;111(7):3770-7
pubmed: 18218850
Bioorg Chem. 2020 Nov;104:104255
pubmed: 32927130
Int J Mol Sci. 2022 Mar 22;23(7):
pubmed: 35408798
Eur J Med Chem. 2021 Feb 15;212:113031
pubmed: 33309473
Lancet Oncol. 2018 Oct;19(10):1315-1327
pubmed: 30219628
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
J Med Chem. 1992 Sep 4;35(18):3319-24
pubmed: 1382133
Eur J Med Chem. 2006 Sep;41(9):1102-7
pubmed: 16828932
Eur J Med Chem. 2018 Jul 15;155:117-134
pubmed: 29885574
J Med Chem. 2019 Aug 8;62(15):7015-7031
pubmed: 31283223
Molecules. 2017 Dec 27;23(1):
pubmed: 29280968
Eur J Cancer. 2022 Jul;170:236-255
pubmed: 35570085
Pharmazie. 1999 Nov;54(11):808-13
pubmed: 10603606
Annu Rev Physiol. 2020 Feb 10;82:103-126
pubmed: 31730395
Bioorg Chem. 2020 Nov;104:104293
pubmed: 33010622
Nat Rev Cancer. 2016 Jun;16(6):345-58
pubmed: 27125352
Nat Rev Cancer. 2019 Jul;19(7):377-391
pubmed: 31209265
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1556-1567
pubmed: 35635148
Mol Divers. 2021 Feb;25(1):291-306
pubmed: 32166485
Future Med Chem. 2018 Sep 1;10(18):2155-2175
pubmed: 30088415
J Adv Pract Oncol. 2022 May;13(4):450-455
pubmed: 35755899
J Med Chem. 2016 Apr 28;59(8):3808-25
pubmed: 27018907
Molecules. 2018 Nov 15;23(11):
pubmed: 30445763
Mol Pharm. 2007 Jul-Aug;4(4):556-60
pubmed: 17530776
Med Chem. 2014;10(5):521-32
pubmed: 24151878
Eur J Pharm Sci. 2013 Jan 23;48(1-2):291-300
pubmed: 23178441
Perspect Medicin Chem. 2007 Sep 17;1:25-38
pubmed: 19812734
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Eur J Cancer. 2018 Mar;92:108-118
pubmed: 29395684
Bioorg Chem. 2020 Mar;96:103656
pubmed: 32062449
Bioorg Med Chem Lett. 2013 Feb 1;23(3):785-90
pubmed: 23260348
Eur J Med Chem. 2009 Mar;44(3):1135-43
pubmed: 18672315
PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006854
pubmed: 30462645
Int J Mol Sci. 2021 Jun 15;22(12):
pubmed: 34203771
Bioorg Chem. 2021 Jul;112:104949
pubmed: 34023640
Molecules. 2015 Nov 03;20(11):19805-22
pubmed: 26540036
N Engl J Med. 2011 Jun 30;364(26):2507-16
pubmed: 21639808
Eur J Med Chem. 2017 Sep 29;138:909-919
pubmed: 28750313
Cancer. 2017 May 1;123(9):1662-1673
pubmed: 28055106
Eur J Cancer. 2016 Mar;55:47-55
pubmed: 26773419
J Med Chem. 2018 Apr 12;61(7):3209-3217
pubmed: 29589443
J Med Chem. 1990 Aug;33(8):2240-54
pubmed: 2374150
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
ISRN Org Chem. 2013 Sep 12;2013:587054
pubmed: 24198971
Bioorg Med Chem. 2008 Jun 1;16(11):6086-102
pubmed: 18468446
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
J Enzyme Inhib Med Chem. 2020 Dec;35(1):85-95
pubmed: 31707866
Curr Med Chem. 2021;28(4):712-749
pubmed: 32026768
Antimicrob Agents Chemother. 2021 Feb 17;65(3):
pubmed: 33257453
Eur J Med Chem. 2012 Aug;54:87-94
pubmed: 22621841
Molecules. 2017 Feb 11;22(2):
pubmed: 28208674
Acta Pharm. 2010 Mar;60(1):55-71
pubmed: 20228041
Lancet Oncol. 2014 Aug;15(9):954-65
pubmed: 25037139
Chemistry. 2014 Nov 3;20(45):14705-14
pubmed: 25251569
Cytokine Growth Factor Rev. 2002 Apr;13(2):119-34
pubmed: 11900988
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5070-6
pubmed: 23937981
J Chem Inf Comput Sci. 2004 May-Jun;44(3):1000-5
pubmed: 15154768
PLoS One. 2017 Aug 10;12(8):e0182022
pubmed: 28797090
Drug Metab Dispos. 2010 Oct;38(10):1836-47
pubmed: 20660102
JAMA Dermatol. 2022 May 1;158(5):495-503
pubmed: 35353115
Bioorg Med Chem Lett. 2017 Oct 15;27(20):4606-4613
pubmed: 28939121
Bioorg Med Chem. 2008 Jul 1;16(13):6601-10
pubmed: 18513976
Lancet. 2012 Jul 28;380(9839):358-65
pubmed: 22735384
N Engl J Med. 2014 Nov 13;371(20):1877-88
pubmed: 25265492
Yakugaku Zasshi. 1962 Sep;82:1246-51
pubmed: 13976097
J Med Chem. 2010 Dec 23;53(24):8688-99
pubmed: 21105712
Bioorg Chem. 2020 Dec;105:104399
pubmed: 33113414
Anticancer Drugs. 2014 Jul;25(6):624-32
pubmed: 24463483
Clin Cancer Res. 2013 Oct 1;19(19):5300-9
pubmed: 24089443
Bioorg Med Chem. 2004 Mar 1;12(5):1129-39
pubmed: 14980625
J Clin Oncol. 2008 Jul 10;26(20):3445-55
pubmed: 18612161
Cancer Manag Res. 2010 Aug 17;2:197-211
pubmed: 21188111